WHO ICTRP trial
Effect of Dexmedetomidine Combined with Remifentanil for Patients with…
ChiCTR2000029105 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000029105 |
|---|---|
| Public title | Effect of Dexmedetomidine Combined with Remifentanil for Patients with Colonoscopy |
| Scientific title | Effect of Dexmedetomidine Combined with Remifentanil for Patients with Colonoscopy |
| Primary sponsor | the Fourth Hospital of Hebei Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Painless Colonoscopy |
| Interventions | Group I:DEX 0.2ug/kg;Group II:DEX 0.3ug/kg;Group III:DEX 0.4ug/kg |
| Registration date | Jan 13, 2020 |
| Target size | Group I:50;Group II:50;Group III:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: